Fassoulaki A, Galanaki E
Department of Anesthesia, St. Savas Hospital, Athens, Greece.
Acta Anaesthesiol Belg. 1989;40(3):179-82.
One hundred and thirty patients scheduled for ENT surgery were randomly allocated to one of the four groups: 3 to 5 minutes before anesthesia the first group (n = 19) received 5 mg of droperidol I.V., the second group (n = 30) 2.5 mg, the third group (n = 32) 0.5 mg and the fourth group (n = 49) received 2 ml of normal saline. Normal saline or droperidol were administered in a double blind manner from 2 ml coded ampules. The postanesthetic incidence of vomiting in the control group was 59% and was found to be significantly higher when compared with the droperidol treated groups (chi2 = 19.5228, P less than 0.0005). The incidence of vomiting in the groups treated with high, moderate or low dose of droperidol varied between 16 and 21% and did not differ significantly between them (chi2 = 0.26035, P greater than 0.80).
130例计划接受耳鼻喉科手术的患者被随机分为四组:麻醉前3至5分钟,第一组(n = 19)静脉注射5毫克氟哌利多,第二组(n = 30)注射2.5毫克,第三组(n = 32)注射0.5毫克,第四组(n = 49)注射2毫升生理盐水。生理盐水或氟哌利多通过2毫升编码安瓿以双盲方式给药。对照组麻醉后呕吐发生率为59%,与氟哌利多治疗组相比显著更高(χ2 = 19.5228,P < 0.0005)。高剂量、中剂量或低剂量氟哌利多治疗组的呕吐发生率在16%至21%之间,组间差异无统计学意义(χ2 = 0.26035,P > 0.80)。